Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden
Article in Vaccines (March 2023)
The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.
Article in Vaccines (March 2023)
Article in Journal of Research in Medical Sciences (December 2022)
Article in Journal of Personalized Medicine (May 2022)